The government has approved a proposal of drug firm Lupin to take more time for completion of its project at Indore Special Economic Zone (SEZ) in Madhya Pradesh, with a proposed investment of Rs 205.69 crore.
The decision to give more time was taken by the the Board of Approval (BoA) in its meeting on 22 April 2019. The board, after deliberations, approved extension of the validity of the letter of permission (LoP) up to 11 April 2020.
The company is setting up its pharma unit in Indore SEZ to manufacture pharmaceutical formulations metered dose inhalers and dry powder inhalers. The company has stated that the delay in apportionment of land resulted in delayed start of the project.